NCT03454711View on ClinicalTrials.gov

Functional Magnetic Resonance Imaging (fMRI) Exploration of Neurocognitive Processes Involved in Food Addiction (FA) in Obese Patients: Towards New Phenotypic Markers for an Optimized Care Pathway

PHASE2/PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 26, 2018

Primary Completion Date

September 8, 2021

Study Completion Date

September 8, 2021

Conditions

Obesity

Interventions

DEVICE

fMRI

Brain MRI

DEVICE

Indirect calorimetry

Resting energy expenditure

DEVICE

Bioimpedance

Measurement of body composition

BIOLOGICAL

Lipid profile, glucose, HBA1c, metabolomic analysis

Blood sample

BEHAVIORAL

YFAS questionnaire, Binge Eating Scale, Hospital Anxiety and Depression (HAD) scale, hedonic evaluation test (liking)

Questionnaires to characterize eating habits and depression

Trial Locations (1)

35033

CHU de Rennes, Rennes

All Listed Sponsors

collaborator

Institut NuMeCan, INRAE 1341

UNKNOWN

lead

Rennes University Hospital

OTHER

NCT03454711 - Functional Magnetic Resonance Imaging (fMRI) Exploration of Neurocognitive Processes Involved in Food Addiction (FA) in Obese Patients: Towards New Phenotypic Markers for an Optimized Care Pathway | Biotech Hunter | Biotech Hunter